Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05CPS
|
|||
| Former ID |
DIB015987
|
|||
| Drug Name |
Dendritic cell vaccine
|
|||
| Synonyms |
Dendritic cell vaccine (injectable, head and neck cancer); Dendritic cell vaccine (injectable, head and neck cancer), National Cancer Institute; Mutant p53 peptide pulsed dendritic cell vaccine (injectable, head and neck cancer), National Cancer Institute
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Head and neck cancer [ICD-11: 2D42] | Phase 1 | [1] | |
| Company |
National Cancer Institute
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00404339) Vaccine Therapy in Treating Patients With Head and Neck Cancer. U.S. National Institutes of Health. | |||
| REF 2 | Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study. Cancer Immunol Immunother. 2004 Jul;53(7):633-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.